X4 Pharmaceuticals XFOR reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM.
Here’s what investors need to know about the announcement.
X4 Pharmaceuticals missed estimated earnings by 18.03%, reporting an EPS of $-0.72 versus an estimate of $-0.61.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.56 which was followed by a 5.08% drop in the share price the next day.
To track all earnings releases for X4 Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.